PetMed Express(PETS) - 2026 Q2 - Quarterly Results

Form 8-K Filing Details This section provides essential administrative information regarding the Form 8-K filing, including registrant details and securities information Registrant Information This section identifies PetMed Express, Inc. as the registrant, detailing its incorporation state, principal executive offices address, and telephone number - Registrant: PetMed Express, Inc.[2] - Address: 420 South Congress Avenue, Delray Beach, Florida 33445[2] - Telephone: (561) 526-4444[2] Securities Information The report lists classes of securities registered under Section 12(b) of the Act, including Common Stock and Preferred Stock Purchase Rights traded on NASDAQ Global Select Market, noting the registrant is not an emerging growth company Registered Securities | Title of each class | Trading Symbol(s) | Name of each exchange on which registered | | :--- | :--- | :--- | | Common Stock, par value $.001 per share | PETS | NASDAQ Global Select Market | | Preferred Stock Purchase Rights | N/A | NASDAQ Global Select Market | - The registrant is not an emerging growth company[4] Item 2.02 Results of Operations and Financial Condition This section details the announcement of fiscal year-end financial results and the Company's approach to non-GAAP financial measures Fiscal Year-End Financial Results Announcement PetMed Express, Inc. announced its March 31, 2025 fiscal year-end financial results and other financial information on October 14, 2025, through a press release furnished as Exhibit 99.1 - PetMed Express, Inc. issued a press release on October 14, 2025, announcing its March 31, 2025 fiscal year-end financial results[5] - A copy of the press release is furnished as Exhibit 99.1 and incorporated by reference[5] Non-GAAP Financial Measures The Company makes reference to non-GAAP financial information in both the press release and the conference call, with a reconciliation to the nearest comparable GAAP financial measures provided in the attached press release - The Company refers to non-GAAP financial information in the press release and conference call[7] - A reconciliation of non-GAAP financial measures to comparable GAAP measures is included in the press release[7] Item 9.01 Financial Statements and Exhibits This section provides a comprehensive list of all financial statements and exhibits accompanying the Form 8-K filing List of Exhibits This section lists the exhibits filed with the Form 8-K, including the press release dated October 14, 2025, and the Cover Page Interactive Data File in Inline XBRL format Exhibits Filed | Exhibit No. | Description | | :--- | :--- | | 99.1 | Press release dated October 14, 2025 | | 104 | Cover Page Interactive Data File (formatted as Inline XBRL) | Cautionary Note Regarding Forward-Looking Statements This section advises that the report contains forward-looking statements, subject to risks and uncertainties that may cause actual results to differ materially, cautioning against undue reliance and clarifying no obligation to update them - The report contains forward-looking statements regarding future events, including the timing of the Form 10-K filing and preliminary unaudited financial results[10] - These statements are subject to risks and uncertainties, and actual results could differ materially due to factors such as the completion of the audit and identification of material adjustments[10] - Readers should not place undue reliance on these statements, which apply only as of the report date, and the Company undertakes no obligation to update them[10] Signatures This section confirms that the report was duly signed on October 14, 2025, by Leslie C.G. Campbell, the Interim Chief Executive Officer and President of PetMed Express, Inc. - The report was signed on October 14, 2025[13] - Signed by Leslie C.G. Campbell, Interim Chief Executive Officer and President (principal executive officer)[13]